Actively Recruiting

Age: 18Years +
All Genders
NCT07003646

Reperfusion Treatment in Acute Pulmonary Embolism

Led by Sahlgrenska University Hospital · Updated on 2026-01-21

220

Participants Needed

13

Research Sites

213 weeks

Total Duration

On this page

Sponsors

S

Sahlgrenska University Hospital

Lead Sponsor

S

Stockholm South General Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

International guidelines recommend immediate reperfusion with systemic thrombolysis (ST) as first-line treatment in high-risk pulmonary embolism (PE). The therapy improves hemodynamics and overall survival but is also associated with a significant risk of severe bleeding. Catheter-directed intervention (CDI) is recommended as an alternative reperfusion therapy in high-risk PE when ST is contraindicated or has failed, as well as in patients who deteriorate or fail to improve during anticoagulation (AC) treatment. Despite lack of high-quality evidence and randomized studies between CDI and standard care, the use of CDI is spreading rapidly in high-risk PE and in less severe PE not fulfilling current treatment criteria.

CONDITIONS

Official Title

Reperfusion Treatment in Acute Pulmonary Embolism

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patients 18 years or older, including pregnant women, with confirmed acute pulmonary embolism by CTPA, angiography, or scintigraphy
  • Planned for or have received catheter-directed intervention or systemic thrombolysis treatment
  • Provided informed consent or waiver applies if patient does not survive before consent can be obtained
Not Eligible

You will not qualify if you...

  • Currently enrolled in another interventional catheter-directed intervention trial
  • Primary reperfusion treatment was surgical embolectomy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 13 locations

1

Aarhus University Hospital

Aarhus, Denmark

Actively Recruiting

2

Rigshospitalet

Copenhagen, Denmark

Actively Recruiting

3

Odense University Hospital

Odense, Denmark

Actively Recruiting

4

Sahlgrenska University Hospital

Gothenburg, Sweden, 41345

Actively Recruiting

5

Linköping University Hospital

Linköping, Sweden

Actively Recruiting

6

Sunderby Hospital

Luleå, Sweden

Actively Recruiting

7

Skåne University Hospital

Lund, Sweden

Actively Recruiting

8

Örebro University Hospital

Örebro, Sweden

Actively Recruiting

9

Danderyd Hospital

Stockholm, Sweden

Actively Recruiting

10

Karolinska University Hospital Huddinge

Stockholm, Sweden

Actively Recruiting

11

Karolinska University Hospital Solna

Stockholm, Sweden

Actively Recruiting

12

Södersjukhuset

Stockholm, Sweden

Actively Recruiting

13

Uppsala University Hospital

Uppsala, Sweden

Not Yet Recruiting

Loading map...

Research Team

F

Freyr Einarsson, MD

CONTACT

A

Annika Odenstedt, coordinator

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Reperfusion Treatment in Acute Pulmonary Embolism | DecenTrialz